Latest Content

Rodney Haring discusses Indigenous navigation, partnerships and prevention strategies to reduce cancer disparities and improve equity in Native communities

The FDA cleared an IND for FG001, allowing a U.S. trial in high-grade glioma, with first patient enrollment expected in second quarter of 2026.

Genentech announces FDA acceptance of giredestrant plus Afinitor for ER-positive, HER2-negative, ESR1-mutated advanced breast cancer treatment.

Thsi overview explains mesothelioma staging, diagnosis, side effects and treatment options from frontline through later lines to guide patient discussions.

Learn about Kaposi sarcoma causes, symptoms and the latest treatment options to help you navigate your diagnosis and talk with your oncologist.

Learn about stage 2 chronic myeloid leukemia, treatment options, side effects, and key questions to guide conversations with your oncologist.

Dr. Rodney Haring discusses strategies to reduce cancer mortality among Native Americans through patient navigation, clinical trials and tribal sovereignty.

Dr. Alex Francoeur of UC Irvine urges patients with ovarian cancer to ask questions, seek second opinions and build trusted relationships with oncologists.

Gratitude didn’t erase my fear, but it gave me something solid to stand on. It became the coping strategy I needed.

Heather Quintana Suchan shares how work and music community support her while she lives fully with stage 4 lung cancer.

Dr. Sara Tolaney discusses how Trodelvy plus Keytruda improves progression-free survival in patients with PD-L1+ metastatic triple-negative breast cancer.

FDA approves Calquence with Venclexta as a first-line option that improved progression-free survival compared with standard chemo in adults with CLL or SLL.